Preoperative Anemia Frequency

Preoperative Evaluation Clinical Trial

Official title:

Preoperative Anemia Frequency

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05808283
• Other study ID #: 2021/20
• Status: Completed
• Start date: November 1, 2021
• Est. completion date: January 31, 2022

Study information

• Verified date: April 2023
• Source: Zonguldak Bulent Ecevit University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In our retrospective study, it was aimed to determine the frequency of anemia in non-emergency patients over the age of 18 who applied to the Anesthesiology and Reanimation Department of our hospital.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 853
• Est. completion date: January 31, 2022
• Est. primary completion date: January 31, 2022
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• -patient over 18 years old,

• Patients applying to the Department of Anesthesiology and Reanimation AD

Exclusion Criteria:

• Pregnant,

• under 18 years old,

• will undergo cardiac and emergency surgery

• Patients with Massive Bleeding

• Patients who underwent multiple surgeries during the study period

Related Conditions & MeSH terms

• Anemia
• Preoperative Evaluation

Intervention

Other:
• preoperative anemia frequency
patients who applied to the outpatient clinic prospectively for 3 months

Locations

Country	Name	City	State
Turkey	Gamze Küçükosman	Zonguldak

Sponsors (1)

Lead Sponsor	Collaborator
Zonguldak Bulent Ecevit University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PREOPERATIVE ANEMIA FREQUENCY AND TREATMENT APPROACH	preoperative anemia frequency	Patients who applied to the outpatient clinic within a 3-month period after ethical approval
Secondary	PREOPERATIVE ANEMIA FREQUENCY AND TREATMENT APPROACH	blood transfusion frequency	Patients who applied to the outpatient clinic within a 3-month period after ethical approval